PARNELL PHARMACEUT HLDGS LTD's ticker is PARNF and the CUSIP is Q73622104. A total of 2 filers reported holding PARNELL PHARMACEUT HLDGS LTD in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $4,000 | -88.6% | 6,800 | -72.0% | 0.00% | -100.0% |
Q3 2016 | $35,000 | -41.7% | 24,300 | -34.0% | 0.00% | 0.0% |
Q2 2016 | $60,000 | +1400.0% | 36,800 | +1944.4% | 0.00% | – |
Q1 2016 | $4,000 | -42.9% | 1,800 | 0.0% | 0.00% | – |
Q4 2015 | $7,000 | +600.0% | 1,800 | +500.0% | 0.00% | – |
Q2 2015 | $1,000 | 0.0% | 300 | 0.0% | 0.00% | – |
Q1 2015 | $1,000 | – | 300 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Endurant Capital Management LP | 448,802 | $732,000 | 0.24% |
SABBY MANAGEMENT, LLC | 389,400 | $635,000 | 0.03% |
ATWOOD & PALMER INC | 16,900 | $28,000 | 0.01% |
Alyeska Investment Group, L.P. | 147,458 | $240,000 | 0.00% |
AlphaMark Advisors, LLC | 400 | $1,000 | 0.00% |
BLACKROCK ADVISORS LLC | 572,696 | $933,000 | 0.00% |
LADENBURG THALMANN FINANCIAL SERVICES INC. | 36,800 | $60,000 | 0.00% |
Cambridge Investment Research Advisors, Inc. | 10,000 | $16,000 | 0.00% |
Tower Research Capital LLC (TRC) | 690 | $1,000 | 0.00% |
Creative Planning | 2,000 | $3,000 | 0.00% |